08:00 , Jan 5, 2009 |  BC Week In Review  |  Company News

Biofield, ValiRx deal

Biofield received an exclusive, worldwide license to distribute a human papillomavirus (HPV) diagnostic test for cervical cancer from ValiRx's ValBio S.A. subsidiary. Biofield purchased a 10% equity stake in ValBio for €600,000 ($807,000) and received...
08:00 , Feb 22, 2000 |  BC Week In Review  |  Company News

Biofield board of directors update

(Management, B8) Biofield Corp. (BZET), Atlanta, Ga.   Business: Diagnostics/Imaging   Appointed: David Long, CEO, as chairman; Amy Langer, executive director of the National Alliance of Breast Cancer Organizations; Raymond Long, orthopedic surgeon; and Arthur...
08:00 , Feb 22, 2000 |  BC Week In Review  |  Company News

Biofield management update

(Board, B7) Biofield Corp. (BZET), Atlanta, Ga.   Business: Diagnostics/Imaging   Hired: David Long as CEO and chairman, formerly president of Abel Laboratories Inc.; Anita Thibeault as president and acting VP of regulatory and clinical...
08:00 , Jan 10, 2000 |  BC Week In Review  |  Company News

Biofield board of directors update

(Management, see below; Financing, B12) Biofield Corp. (BZET), Atlanta, Ga.   Business: Diagnostics/Imaging   Appointed: David Long, private investor   Resigned: C. Leonard Gordon as chairman; and Harvey Horowitz  ...
08:00 , Jan 10, 2000 |  BC Week In Review  |  Company News

Biofield management update

(Board, see above; Financing, B12) Biofield Corp. (BZET), Atlanta, Ga.   Business: Diagnostics/Imaging   Resigned: D. Carl Long, as president, CEO and a director  ...
08:00 , Dec 7, 1998 |  BC Week In Review  |  Company News

Biofield cancer, diagnostics/imaging news

BZET will reduce headcount to less than 10 employees from 35 and eliminate substantially all of its operations to reduce costs. BZET said it no longer meets the requirements to list on the NASDAQ National...
07:00 , Aug 3, 1998 |  BC Week In Review  |  Clinical News

Breast cancer diagnostic system: Approved in Europe

Imperial Cancer Research Fund (London, U.K.) researchers and colleagues published in The Lancet the ability of BZET's Biofield Diagnostic System, which uses skin surface electropotential measurements, to discriminate between breast cancer and benign lesions as...
07:00 , Sep 2, 1997 |  BC Week In Review  |  Company News

Biofield management update

Biofield Corp. (BZET), Atlanta, Ga.   Business: Diagnostics/Imaging   Hired: Robert Johnson as COO, formerly SVP of business development at Healthdyne Technologies Inc.; Todd Polk as VP of regulatory and clinical affairs, formerly VP of...
07:00 , Aug 4, 1997 |  BC Week In Review  |  Company News

Biofield management update

Biofield Corp. (BZET), Atlanta, Ga.   Business: Diagnostics/Imaging   Hired: Michael Adams as VP of regulatory affairs and quality assurance; formerly VP of regulatory affairs and quality assurance at Cytyc Corp. ; and Edward Schroeppel,...
07:00 , Jun 2, 1997 |  BC Week In Review  |  Clinical News

Biofield regulatory update

BZET said it is discussing with the FDA the protocol for a proposed 300-400 patient confirmatory trial of its cancer diagnostic system. The agency refused to file the company's original PMA in February. BZET estimated...